Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 501 shares at $155.45 ($78K) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Open-market sale of $78k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.54 | 216 | $33K | 42.9% |
| 2 | $155.45 | 170 | $26K | 34.0% |
| 3 | $156.38 | 100 | $16K | 20.1% |
| 4 | $157.30 | 14 | $2K | 2.8% |
| 5 | $158.09 | 1 | $158 | 0.2% |
| Total | $155.30 avg | 501 |
| $78K |
| 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |